Indeed, a recent study by Ren et al. [66] has found that when used in combination with MAPK kinase (MEK) inhibitors, a small molecule activator of BMP signalling, tacrolimus (also called FK506), could effectively suppress metastasis in the MDA-MB-231 tumor model. This evidence concerns the gene MAP2K7 and neoplasm.